Answers are grounded in this paper and cite their sources.
BACKGROUND: Gaucher disease is a lysosomal storage disorder caused by mutations in the GBA1 gene, leading to a deficiency of the enzyme glucocerebrosidase (GCase). Current enzyme replacement therapies are expensive due to production in mammalian systems. This study aimed to evaluate the expression of codon-optimized GCase in Pichia pastoris GlycoSwitch ® strains as a cost-effective alternative. METHODS: A codon-optimized GBA1 gene was cloned into the pJAG-s1 vector and used to transform P. pastoris GlycoSwitch ® colonies. Positive transformants were induced with methanol for 72 h. Protein expression was assessed in both supernatant and cell lysates using western blot analysis. RESULTS: Although successful cloning and transformation were confirmed by polymerase chain reaction and sequencing, no detectable GCase expression was observed in any of the analyzed colonies, either intracellularly or extracellularly. CONCLUSIONS: Codon optimization alone is insufficient to enable recombinant expression of GCase in P. pastoris . Additional strategies, including optimization of expression elements and posttranslational processing, are required.
No takes yet. Share an insight, caveat, or question.
Morosini et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: